Nick P. Bird

发表

The effects of conventional physical therapy and eccentric strengthening for insertional achilles tendinopathy.

S. Ishikawa, D. Richardson, G. Murphy, 2014, International journal of sports physical therapy.

A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [ 18 F ] FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer ’ s Disease

Thomas E. Nichols, P. Matthews, Brandon Whitcher, 2010 .

Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough

David G. Behm, S. Birring, J. Smith, 2021, ERJ Open Research.

Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18F-FDG PET study

P. Matthews, E. Reiman, E. Rabiner, 2009, Alzheimer's & Dementia.

Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial

J. H. Rudd, E. Vamvaka, J. Tarkin, 2020, BMJ Open.

Low- dose i nterleukin 2 for the reduction of v ascular inflammati o n in acute corona ry syndromes (IVORY): protocol and study rationale for a randomised, double- blind, placebo- controlled, phase II clinical trial

J. H. Rudd, E. Vamvaka, J. Tarkin, 2022 .

Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury

P. Anand, B. Chizh, J. Palmer, 2011, European journal of pain.

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.

Thomas E. Nichols, P. Matthews, Brandon Whitcher, 2011, Journal of Alzheimer's disease : JAD.

A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying

Thomas E. Nichols, P. Matthews, Brandon Whitcher, 2010 .